Titan Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

8.26

8.26

8.26

8.26

8.26

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

136.87

120.18

97.83

77.98

57.56

Loan funds

Secured loans

2.10

7.17

7.00

5.80

7.54

Unsecured loans

-

-

-

-

-

Total

147.24

135.61

113.09

92.04

73.36

Uses of funds

Fixed assets

Gross block

78.22

52.01

35.89

47.89

38.34

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

20.95

-

-

12.90

11.30

Net block

57.27

52.01

35.89

34.99

27.04

Capital work-in-progress

1.70

2.55

13.29

3.63

0.27

Investments

24.50

23.18

11.59

4.03

1.27

Net current assets

Current assets, loans & advances

82.97

73.82

69.92

64.91

57.59

Less : current liabilities & provisions

19.20

15.96

17.61

15.52

12.81

Total net current assets

63.77

57.87

52.32

49.39

44.77

Miscellaneous expenses not written

-

-

-

-

-

Total

147.24

135.61

113.09

92.04

73.36

Notes:

Book value of unquoted investments

24.50

23.18

11.59

4.03

1.27

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

7.78

12.90

1.13

3.20

0.77

Number of equity sharesoutstanding (Lacs)

82.64

82.64

82.64

82.64

82.64